In vivo demyelinating activity of sera from animals with chronic experimental allergic encephalomyelitis Antibody nature of the demyelinating factor and the role of complement

[1]  H. Lassmann,et al.  Pathogenetic aspects of demyelinating lesions in chronic relapsing experimental allergic encephalomyelitis: possible interaction of cellular and humoral immune mechanisms. , 1983, Progress in brain research.

[2]  H. Wiśniewski,et al.  Antibodies-restricted heterogeneity in serum and cerebrospinal fluid of chronic relapsing experimental allergic encephalomyelitis , 1982, Journal of Neuroimmunology.

[3]  H. Wiśniewski,et al.  Immunologic studies of chronic relapsing EAE in guinea pigs: similarities to multiple sclerosis. , 1981, Journal of immunology.

[4]  R. Schreiber,et al.  Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity , 1981, The Journal of experimental medicine.

[5]  D. Kraft,et al.  Lack of evidence for IgM-induced ADCC: studies with monoclonal and polyclonal antibodies. , 1981, Immunology.

[6]  C. Brosnan,et al.  Experimental allergic encephalomyelitis Characterization of serum factors causing demyelination and swelling of myelin , 1981, Journal of the Neurological Sciences.

[7]  H. Wiśniewski,et al.  Isolated leptomeninges of the spinal cord: an ideal tool to study inflammatory reaction in EAE. , 1981, Acta neuropathologica. Supplementum.

[8]  P. Dowling,et al.  The role of autoantibody and immune complexes in the pathogenesis of Guillain‐Barre syndrome , 1981, Annals of neurology.

[9]  K. J. Dorrington,et al.  Fcγ Receptor of the Murine Macrophage-Like Cell Line P388D1 I. The Binding of Homologous and Heterologous Immunoglobulin G , 1979 .

[10]  D. Silberberg,et al.  PERIPHERAL NERVE DEMYELINATION INDUCED BY INTRANEURAL INJECTION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS SERUM , 1979, Journal of neuropathology and experimental neurology.

[11]  G. Mckhann,et al.  Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange , 1979, Annals of neurology.

[12]  R. Lebar,et al.  STUDIES ON AUTOIMMUNE ENCEPHALOMYELITIS IN THE GUINEA PIG—TIT. A COMPARATIVE STUDY OF TWO AUTOANTIGENS OF CENTRAL NERVOUS SYSTEM MYELIN 1 , 1979, Journal of neurochemistry.

[13]  D. Silberberg,et al.  Antiserum-mediated demyelination in vivo: a sequential study using intraneural injection of experimental allergic neuritis serum. , 1978, Laboratory investigation; a journal of technical methods and pathology.

[14]  D. Kraft,et al.  Separation and characterization of anti-benzyl-penicilloyl (BPO) antibodies. I. Biochemical and biophysical properties of anti-BPO-IgG obtained by affinity and subsequent ion-exchange chromatography , 1978 .

[15]  D. Silberberg,et al.  Transfer of demyelination by intraneul injection of experimental allergic neuritis serum , 1978, Nature.

[16]  C. Raine,et al.  Antiserum-induced dissociation of myelinogenesis in vitro. An ultrastructural study. , 1978, Laboratory investigation; a journal of technical methods and pathology.

[17]  H. Wiśniewski,et al.  Studies on demyelination by activated lymphocytes in the rabbit eye. II. Antibody-dependent cell-mediated demyelination. , 1977, Journal of immunology.

[18]  H. Wiśniewski,et al.  Chronic relapsing experimental allergic encephalomyelitis: An experimental model of multiple sclerosis , 1977, Annals of neurology.

[19]  Raine Cs,et al.  The initial structural lesion in serum-induced demyelination in vitro. , 1976 .

[20]  C. Bernard.  EXPERIMENTAL AUTOIMMUNE ENCEPHALO‐MYELITIS IN MICE: GENETIC CONTROL OF SUSCEPTIBILITY * , 1976, Journal of immunogenetics.

[21]  J. Boutry,et al.  Studies on autoimmune encephalomyelitis in the guinea pig. II. An in vitro investigation on the nature, properties, and specificity of the serum-demyelinating factor. , 1976, Journal of immunology.

[22]  J. Simon,et al.  Effect of passive transfer of anti-brain antibodies to a normal recipient , 1975, Experimental Neurology.

[23]  N. Tamura.  An incompatibility in the reaction of the second component of human complement with the fourth component of guinea-pig complement. , 1970, Immunology.

[24]  M. Polley,et al.  Human Monocytes: Distinct Receptor Sites for the Third Component of Complement and for Immunoglobulin G , 1968, Science.

[25]  E. Alvord,et al.  The in vitro demyelinating activity of sera from guinea pigs sensitized with whole CNS and with purified encephalitogen. , 1968, Experimental neurology.

[26]  B. Jankovič,et al.  Passive Transfer of ‘Allergic’ Encephalomyelitis with Antibrain Serum injected into the Lateral Ventricle of the Brain , 1965, Nature.

[27]  S. Appel,et al.  THE APPLICATION OF TISSUE CULTURE TO THE STUDY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS , 1964, The Journal of experimental medicine.

[28]  E. Einstein,et al.  THE ISOLATION FROM BOVINE SPINAL CORD OF A HOMOGENEOUS PROTEIN WITH ENCEPHALITOGENIC ACTIVITY * , 1962, Journal of neurochemistry.

[29]  L. Levine,et al.  Quantitative micro-complement fixation and its use in the study of antigenic structure by specific antigen-antibody inhibition. , 1961, Journal of immunology.

[30]  S. Appel,et al.  The application of tissue culture to the study of experimental, “allergic” encephalomyelitis: I. Patterns Of demyelination , 1961 .

[31]  Richard P. Bunge,et al.  Electron Microscopic Study of Demyelination in an Experimentally Induced Lesion in Adult Cat Spinal Cord , 1960, The Journal of biophysical and biochemical cytology.

[32]  P. Y. Paterson.  TRANSFER OF ALLERGIC ENCEPHALOMYELITIS IN RATS BY MEANS OF LYMPH NODE CELLS , 1960, The Journal of experimental medicine.

[33]  Waksman Bh,et al.  Tuberculin Type Sensitivity to Spinal Cord Antigen in Rabbits with Isoallergic Encephalomyelitis , 1951 .